351369-12-5 Usage
General Description
Carbamic acid, (4-fluoro-3-pyrrolidinyl)-, 1,1-dimethylethyl ester (9CI) is an organic compound with potential applications in chemical research and pharmaceutical manufacturing. This specific chemical is characterized by a 4-fluoro-3-pyrrolidinyl group which relates it to the chemical class of pyrrolidines, a type of organic compound that contains a five-membered nitrogenous ring structure. As an ester of carbamic acid, it contains a carbamate functional group, which includes a carbonyl (a carbon-oxygen double bond) and an amine (a nitrogen with attached hydrogens and/or carbon groups). The '1,1-dimethylethyl ester' part of its name refers to the specific arrangement of atoms in the ester portion of the molecule. Its chemical structure strongly determines its potential applications and reactivity in various chemical reactions. The (9CI) indicates that this particular nomenclature was approved by the Ninth Collective Index (9CI), an internationally recognized practice for chemical names and structures.
Check Digit Verification of cas no
The CAS Registry Mumber 351369-12-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,1,3,6 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 351369-12:
(8*3)+(7*5)+(6*1)+(5*3)+(4*6)+(3*9)+(2*1)+(1*2)=135
135 % 10 = 5
So 351369-12-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H17FN2O2/c1-9(2,3)14-8(13)12-7-5-11-4-6(7)10/h6-7,11H,4-5H2,1-3H3,(H,12,13)
351369-12-5Relevant articles and documents
Quinolizinone type compounds
-
, (2008/06/13)
Antibacterial compounds having the formula STR1 and the pharmaceutically acceptable salts, esters and amides thereof, preferred examples of which include those compounds wherein A is =CR6 --; R1 is cycloalkyl of from three to eight carbon atoms or substituted phenyl; R2 is selected from the group consisting of STR2 R3 is halogen; R4 is hydrogen, loweralkyl, a pharmaceutically acceptable cation, or a prodrug ester group; R5 is hydrogen, loweralkyl, halo(loweralkyl), or --NR13 R14 ; and R6 is halogen, loweralkyl, halo(loweralkyl), hydroxy-substituted loweralkyl, loweralkoxy(loweralkyl), loweralkoxy, or amino(loweralkyl), as well as pharmaceutical compositions containing such compounds and the use of the same in the treatment of bacterial infections.
